Ives Jeffrey L. 4
4 · Cara Therapeutics, Inc. · Filed Jul 19, 2022
Insider Transaction Report
Form 4
Ives Jeffrey L.
Director
Transactions
- Sale
Common Stock
2022-07-15$9.05/sh−3,600$32,580→ 15,476 total
Footnotes (2)
- [F1]Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on June 15, 2022.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.97 to $9.37, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.